Explore

Rapid Read Rapid Read
Scientists Discover Antibodies Offering New Hope Against Measles Resurgence

Scientists Discover Antibodies Offering New Hope Against Measles Resurgence

Researchers have isolated four potent antibodies from a vaccinated individual that could lead to new treatments for measles, a highly contagious disease making a comeback in the U.S. Despite the availability of a highly effective vaccine, declining vaccination rates have led to outbreaks. The antibodies, discovered by scientists at the La Jolla Institute for Immunology, could provide a treatment option for those exposed to the virus, particularly for individuals who cannot be vaccinated. The study, published in the journal Cell Host & Microbe, emphasizes that this approach is not a substitute for vaccination.
Rapid Read Rapid Read
Phage Therapy Gains Renewed Interest as Antibiotic Alternative

Phage Therapy Gains Renewed Interest as Antibiotic Alternative

Phage therapy, which uses viruses to target and kill bacteria, is experiencing a resurgence as an alternative to antibiotics. Historically used in Europe and the former Soviet Union, phage therapy was overshadowed by antibiotics due to their broad-spectrum efficacy. However, with rising antibiotic resistance, phage therapy is being reconsidered for its potential to treat infections that antibiotics cannot cure. The therapy requires precise matching of phages to pathogens, posing challenges in empirical treatments. Recent studies highlight the need for robust strategies to tailor phage selection and dosing to specific infections.
Rapid Read Rapid Read
Researcher Michael Peluso Advances Long COVID Understanding with Innovative Tissue Bank

Researcher Michael Peluso Advances Long COVID Understanding with Innovative Tissue Bank

Dr. Michael Peluso, an infectious disease specialist at the University of California, San Francisco, is leading efforts to understand and treat long COVID through the Long-term Impact of Infection with Novel Coronavirus (LIINC) research program. Initiated in April 2020, the program focuses on the biological, immunological, and clinical changes in individuals suffering from long COVID. A unique aspect of LIINC is its tissue bank, which collects and analyzes tissue samples from long COVID patients to inform clinical trials and potential treatments. Dr. Peluso's work builds on his experience with HIV research, applying similar methodologies to explore the persistence of SARS-CoV-2 in the body. The program has enrolled over 1,800 participants and shared thousands of biospecimens with other research labs.
Rapid Read Rapid Read
Study Explores Dual Role of Host LncRNAs in Viral Infections

Study Explores Dual Role of Host LncRNAs in Viral Infections

A comprehensive review has highlighted the complex role of long non-coding RNAs (lncRNAs) in viral infections, illustrating their dual function as both defenders and collaborators in host-virus interactions. The study discusses how lncRNAs can modulate immune responses and influence viral replication. Some lncRNAs act as antiviral agents by enhancing immune signaling, while others are hijacked by viruses to suppress host defenses and facilitate replication. The review categorizes lncRNAs into antiviral, proviral, and bifunctional types, emphasizing their context-dependent roles. This duality is influenced by factors such as viral strain, host cell type, and infection stage, making lncRNAs potential targets for therapeutic interventions.
Rapid Read Rapid Read
GLP-1 Drugs Show Promise in Reducing Heart Attack Risk by 13%

GLP-1 Drugs Show Promise in Reducing Heart Attack Risk by 13%

Recent research has highlighted the potential of GLP-1 receptor agonists, commonly used as weight loss drugs, to reduce the risk of heart attacks and other cardiovascular events by 13%. The study, involving over 90,000 patients, found that these drugs not only aid in weight management but also offer significant cardiovascular benefits. The findings suggest that GLP-1 drugs could play a crucial role in preventing heart disease, particularly among individuals with high cardiovascular risk, type 2 diabetes, or obesity.
Rapid Read Rapid Read
Research Identifies Host Oxidative Stress as a Catalyst for Mycobacterial Antibiotic Resistance

Research Identifies Host Oxidative Stress as a Catalyst for Mycobacterial Antibiotic Resistance

A recent study has revealed that host-induced oxidative stress can prime mycobacteria for rapid evolution of antibiotic resistance. The research focused on Mycobacterium smegmatis (Msm) and its response to low-dose isoniazid (INH) exposure. The study found that brief exposure to sub-inhibitory levels of INH enriched sub-populations of Msm with low-level resistance and tolerance, without significant fitness trade-offs. This resistance was linked to mutations in specific genes, such as ohrR, mfs1, and ntaA_5, which were found to confer low-level resistance. The study suggests that these mutations can potentiate the rapid acquisition of high-level resistance, highlighting the role of oxidative stress in accelerating resistance evolution. The findings underscore the potential for adjunct therapies targeting oxidative stress defenses to enhance the efficacy of traditional antibiotics.
Rapid Read Rapid Read
SKYRIZI® (risankizumab) Gains Approval in Ontario and Alberta for Ulcerative Colitis Treatment

SKYRIZI® (risankizumab) Gains Approval in Ontario and Alberta for Ulcerative Colitis Treatment

SKYRIZI® (risankizumab), a medication developed by AbbVie, has been approved for inclusion in the public drug formularies of Ontario and Alberta for the treatment of moderately to severely active ulcerative colitis (UC). This development follows positive reimbursement recommendations for both Crohn's disease and ulcerative colitis. SKYRIZI® is a humanized monoclonal antibody that targets interleukin-23 (IL-23), a cytokine involved in inflammatory processes. The drug is intended for patients who have not responded adequately to conventional therapies, biologic treatments, or Janus kinase (JAK) inhibitors. The listing in these provinces is part of a broader effort to make SKYRIZI® accessible across Canada, with similar listings already in place in Quebec, Nova Scotia, and Prince Edward Island.
Rapid Read Rapid Read
Cranberry Juice Shows Potential in Combating Drug-Resistant Bacteria

Cranberry Juice Shows Potential in Combating Drug-Resistant Bacteria

A study published in Applied and Environmental Microbiology suggests that compounds in cranberry juice may help slow the emergence of drug-resistant bacteria, particularly in urinary tract infections (UTIs). The research, conducted by the Institut national de la recherche scientifique (INRS) in Canada, found that cranberry juice compounds can enhance the efficacy of antibiotics against E.coli strains responsible for most UTIs. The study highlights the potential of cranberry juice as a natural adjuvant to boost antibiotic effectiveness and suppress the emergence of resistant bacterial mutations.
Trendline Trendline
GC Biopharma to Present IVIG Product Research at CIS Annual Meeting

GC Biopharma to Present IVIG Product Research at CIS Annual Meeting

GC Biopharma to Present IVIG Product Research at CIS Annual Meeting
Trendline Trendline
GC Biopharma to Present IVIG Product Research at 2026 CIS Annual Meeting

GC Biopharma to Present IVIG Product Research at 2026 CIS Annual Meeting

GC Biopharma to Present IVIG Product Research at 2026 CIS Annual Meeting
Rapid Read Rapid Read
Nassau County Confirms First Measles Case Since 2024 in Unvaccinated Child

Nassau County Confirms First Measles Case Since 2024 in Unvaccinated Child

The Nassau County Health Department has confirmed a case of measles in an unvaccinated child under five years old, marking the first such case in the county since 2024. The child, who does not attend school or daycare, tested positive for measles, a highly contagious respiratory virus. The county is collaborating with the New York State Health Department to investigate the case and implement measures to prevent further spread. Measles can lead to severe complications, including pneumonia and encephalitis, and is preventable through vaccination. Health officials are urging residents to ensure they are up to date with the measles, mumps, and rubella (MMR) vaccine, which is considered safe and effective.
Trendline Trendline
The Discovery of Ozempic: A Breakthrough in Diabetes and Obesity Treatment

The Discovery of Ozempic: A Breakthrough in Diabetes and Obesity Treatment

The Discovery of Ozempic: A Breakthrough in Diabetes and Obesity Treatment